These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
602 related items for PubMed ID: 15140937
1. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. Zhang B, Higuchi M, Yoshiyama Y, Ishihara T, Forman MS, Martinez D, Joyce S, Trojanowski JQ, Lee VM. J Neurosci; 2004 May 12; 24(19):4657-67. PubMed ID: 15140937 [Abstract] [Full Text] [Related]
2. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VM. Neuron; 1999 Nov 12; 24(3):751-62. PubMed ID: 10595524 [Abstract] [Full Text] [Related]
3. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. Proc Natl Acad Sci U S A; 2003 Aug 19; 100(17):9980-5. PubMed ID: 12872001 [Abstract] [Full Text] [Related]
4. Tau and axonopathy in neurodegenerative disorders. Higuchi M, Lee VM, Trojanowski JQ. Neuromolecular Med; 2002 Aug 19; 2(2):131-50. PubMed ID: 12428808 [Abstract] [Full Text] [Related]
5. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Gilley J, Seereeram A, Ando K, Mosely S, Andrews S, Kerschensteiner M, Misgeld T, Brion JP, Anderton B, Hanger DP, Coleman MP. Neurobiol Aging; 2012 Mar 19; 33(3):621.e1-621.e15. PubMed ID: 21492964 [Abstract] [Full Text] [Related]
10. Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies. Higuchi M, Zhang B, Forman MS, Yoshiyama Y, Trojanowski JQ, Lee VM. J Neurosci; 2005 Oct 12; 25(41):9434-43. PubMed ID: 16221853 [Abstract] [Full Text] [Related]
11. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, Trojanowski J, Lee VM. Neuron; 2002 Aug 01; 35(3):433-46. PubMed ID: 12165467 [Abstract] [Full Text] [Related]
13. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice. Onishi T, Matsumoto Y, Hattori M, Obayashi Y, Nakamura K, Yano T, Horiguchi T, Iwashita H. Neurosci Res; 2014 Mar 01; 80():76-85. PubMed ID: 24406748 [Abstract] [Full Text] [Related]
15. Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VM. Mol Biol Cell; 2000 Dec 01; 11(12):4093-104. PubMed ID: 11102510 [Abstract] [Full Text] [Related]
17. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein. Feuillette S, Miguel L, Frébourg T, Campion D, Lecourtois M. J Neurochem; 2010 May 01; 113(4):895-903. PubMed ID: 20193038 [Abstract] [Full Text] [Related]